Importantly, we found that 280 mRNAs of significantly dysregulation in NAFLD were reversed by SSJZF treatment (Figure 3(B,C)), which were enriched in 10 KEGG pathways such as fatty acid metabolism, glucagon signalling pathway, PPAR signalling pathway and arachidonic acid metabolism (Figure 3(D)). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.